Biocept Inc logo

BIOC - Biocept Inc News Story

$4.4 0.1  2.8%

Last Trade - 3:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £41.7m
Enterprise Value £33.1m
Revenue £20.0m
Position in Universe 5560th / 6841

BRIEF-Biocept - Study Shows Co's Target Selector May Provide More Robust Method For Detecting Lung Cancer Metastasis In Cerebrospinal Fluid Than Cytology

Mon 5th October, 2020 1:36pm
Oct 5 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT - STUDY SHOWS CO'S TARGET SELECTOR MAY PROVIDE
MORE
ROBUST METHOD FOR DETECTING LUNG CANCER METASTASIS IN
CEREBROSPINAL FLUID THAN CYTOLOGY

Source text for Eikon:  ID:nPnbttHnYa 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.